Skip to main content
. Author manuscript; available in PMC: 2016 Apr 8.
Published in final edited form as: Nature. 2015 Sep 30;526(7572):218–223. doi: 10.1038/nature15400

Extended Data Figure 1. Identification of SERINC3 as a candidate target of Nef and glycoGag.

Extended Data Figure 1

a, Anti-HIV-1 CA immunoblot of Nef+, Nef−, and glycoMA+ HIV-1 virions harvested from the indicated fractions of OptiPrep gradients. b, Proteins identified by mass spectrometry in Nef− but not in Nef+ or glycoMA+ virion lysates. The data are from two independent experiments.